Brief: 4D Molecular Therapeutics Q1 Net Income USD -68.76 Million Vs. IBES Estimate USD -62.6 Million
07/05/2026 21:05
May 07 (Reuters) - 4D Molecular Therapeutics Q1 operating expenses USD 76.667 million. Q1 operating income USD -73.62 million vs. IBES estimate USD -66.5 million Q1 basic EPS USD -1.01 Q1 revenue USD 3.047 million
Recent news on 4D Molecular Therapeutics
See all newsBrief: 4D Molecular Therapeutics Q1 Net Income USD -68.76 Million Vs. IBES Estimate USD -62.6 Million
U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan
Brief: 4Dmt Completes Enrollment For 4Front-1 Phase 3 Clinical Trial Of 4D-150 In Wet AMD
Brief: 4Dmt Provides Company Update And Anticipated Development Milestones For 2026
U.S. RESEARCH ROUNDUP-Cencora, Eagle Materials, Honeywell